MARKET

SLNO

SLNO

Soleno Therapeutics Inc
NASDAQ
39.68
+1.11
+2.88%
After Hours: 39.74 +0.06 +0.15% 19:52 03/06 EST
OPEN
38.09
PREV CLOSE
38.57
HIGH
39.74
LOW
37.50
VOLUME
1.76M
TURNOVER
--
52 WEEK HIGH
90.32
52 WEEK LOW
32.63
MARKET CAP
2.13B
P/E (TTM)
101.51
1D
5D
1M
3M
1Y
5Y
1D
Soleno Therapeutics Earnings Call Highlights Surging Launch
TipRanks · 5h ago
Analysts Are Bullish on These Healthcare Stocks: Sionna Therapeutics, Inc. (SION), Privia Health Group (PRVA)
TipRanks · 1d ago
Investor Notice: Robbins LLP Informs Investors of the Soleno Therapeutics, Inc. Class Action Lawsuit
Barchart · 2d ago
Soleno Therapeutics Files Initial Beneficial Ownership Statement for CFO Jennifer Fulk
Reuters · 4d ago
Soleno Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 4d ago
Soleno Therapeutics Price Target Cut to $100.00/Share From $120.00 by HC Wainwright & Co.
Dow Jones · 4d ago
HC Wainwright & Co. Maintains Buy on Soleno Therapeutics, Lowers Price Target to $100
Benzinga · 4d ago
SOLENO THERAPEUTICS, INC. <SLNO.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $100 FROM $120
Reuters · 4d ago
More
About SLNO
Soleno Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing novel therapeutics for the treatment of rare diseases. The Company’s lead product candidate, diazoxide choline extended-release tablets (DCCR), is for the treatment of Prader-Willi syndrome (PWS) in individuals four years and older who have hyperphagia. DCCR contains diazoxide choline, a potent ATP-sensitive potassium (KATP) channel activator. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine. Its proposed mode of action, with targets in the brain, pancreas and fat tissue, has the potential to broadly impact complex diseases like PWS to reduce appetite, reduce food-seeking, decrease insulin and leptin resistance, and reduce body fat. The Company has Breakthrough Therapy and Fast-Track designations in the United States and Orphan Drug designations in the United States and European Union.

Webull offers Soleno Therapeutics Inc stock information, including NASDAQ: SLNO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLNO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLNO stock methods without spending real money on the virtual paper trading platform.